Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |